STAAR Surgical Company (STAA)Stock Price, SEC 13D/G, News & Info

#ThinkSabio, SEC-Update:STAA :$31.22

Sector: Healthcare
YTD: 5.01 %
1 Yr : -24.64%

SEC reported Today (06-SEP-2024) that BAILLIE GIFFORD CO has DECREASED #STAA shares

Before: 3,682,382 Shares
Now: 1,562,669 Shares
Status: DECREASED by -58.00%
Ownership: 3.18%

Read Report:

https://www.thinksabio.com/search/report/subtype=individual_statistical_report&symbols=STAA&type=symbol

STAAR Surgical Company (STAA)

Reffered From YAHOO Finance :

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Leave a Reply

Your email address will not be published. Required fields are marked *